134 related articles for article (PubMed ID: 17389535)
1. How physicians approach prostate cancer screening before and after losing a lawsuit.
Krist AH; Woolf SH; Johnson RE
Ann Fam Med; 2007; 5(2):120-5. PubMed ID: 17389535
[TBL] [Abstract][Full Text] [Related]
2. Patient education on prostate cancer screening and involvement in decision making.
Krist AH; Woolf SH; Johnson RE; Kerns JW
Ann Fam Med; 2007; 5(2):112-9. PubMed ID: 17389534
[TBL] [Abstract][Full Text] [Related]
3. Unwanted control: how patients in the primary care setting decide about screening for prostate cancer.
Woolf SH; Krist AH; Johnson RE; Stenborg PS
Patient Educ Couns; 2005 Jan; 56(1):116-24. PubMed ID: 15590232
[TBL] [Abstract][Full Text] [Related]
4. Patient perceptions of how physicians communicate during prostate cancer screening discussions: a comparison of residents and faculty.
Kerns JW; Krist AH; Woolf SH; Flores SK; Johnson RE
Fam Med; 2008 Mar; 40(3):181-7. PubMed ID: 18320396
[TBL] [Abstract][Full Text] [Related]
5. Screening for prostate cancer with the prostate-specific antigen test: are patients making informed decisions?
O'Dell KJ; Volk RJ; Cass AR; Spann SJ
J Fam Pract; 1999 Sep; 48(9):682-8. PubMed ID: 10498074
[TBL] [Abstract][Full Text] [Related]
6. Testing the effects of a decision aid for prostate cancer screening.
Rubel SK; Miller JW; Stephens RL; Xu Y; Scholl LE; Holden EW; Stroud LA; Volk RJ
J Health Commun; 2010 Apr; 15(3):307-21. PubMed ID: 20432110
[TBL] [Abstract][Full Text] [Related]
7. Prostate cancer screening and informed decision-making: provider and patient perspectives.
Bowen DJ; Hannon PA; Harris JR; Martin DP
Prostate Cancer Prostatic Dis; 2011 Jun; 14(2):155-61. PubMed ID: 21243007
[TBL] [Abstract][Full Text] [Related]
8. Randomized trial examining the effect of two prostate cancer screening educational interventions on patient knowledge, preferences, and behaviors.
Partin MR; Nelson D; Radosevich D; Nugent S; Flood AB; Dillon N; Holtzman J; Haas M; Wilt TJ
J Gen Intern Med; 2004 Aug; 19(8):835-42. PubMed ID: 15242468
[TBL] [Abstract][Full Text] [Related]
9. A community-based intervention to promote informed decision making for prostate cancer screening among Hispanic American men changed knowledge and role preferences: a cluster RCT.
Chan EC; McFall SL; Byrd TL; Mullen PD; Volk RJ; Ureda J; Calderon-Mora J; Morales P; Valdes A; Kay Bartholomew L
Patient Educ Couns; 2011 Aug; 84(2):e44-51. PubMed ID: 21237611
[TBL] [Abstract][Full Text] [Related]
10. Pairing physician education with patient activation to improve shared decisions in prostate cancer screening: a cluster randomized controlled trial.
Wilkes MS; Day FC; Srinivasan M; Griffin E; Tancredi DJ; Rainwater JA; Kravitz RL; Bell DS; Hoffman JR
Ann Fam Med; 2013; 11(4):324-34. PubMed ID: 23835818
[TBL] [Abstract][Full Text] [Related]
11. Prostate specific antigen screening for prostate cancer: knowledge of, attitudes towards, and utilization among primary care physicians.
Tasian GE; Cooperberg MR; Cowan JE; Keyashian K; Greene KL; Daniels NA; Carroll PR; Chan JM
Urol Oncol; 2012; 30(2):155-60. PubMed ID: 20800514
[TBL] [Abstract][Full Text] [Related]
12. Prostate cancer screening decisions: results from the National Survey of Medical Decisions (DECISIONS study).
Hoffman RM; Couper MP; Zikmund-Fisher BJ; Levin CA; McNaughton-Collins M; Helitzer DL; VanHoewyk J; Barry MJ
Arch Intern Med; 2009 Sep; 169(17):1611-8. PubMed ID: 19786681
[TBL] [Abstract][Full Text] [Related]
13. Internet patient decision support: a randomized controlled trial comparing alternative approaches for men considering prostate cancer screening.
Frosch DL; Bhatnagar V; Tally S; Hamori CJ; Kaplan RM
Arch Intern Med; 2008 Feb; 168(4):363-9. PubMed ID: 18299490
[TBL] [Abstract][Full Text] [Related]
14. Educating men about prostate cancer screening. A randomized trial of a mailed pamphlet.
Wilt TJ; Paul J; Murdoch M; Nelson D; Nugent S; Rubins HB
Eff Clin Pract; 2001; 4(3):112-20. PubMed ID: 11434074
[TBL] [Abstract][Full Text] [Related]
15. Informed decision making on PSA testing for the detection of prostate cancer: an evaluation of a leaflet with risk indicator.
van Vugt HA; Roobol MJ; Venderbos LD; Joosten-van Zwanenburg E; Essink-Bot ML; Steyerberg EW; Bangma CH; Korfage IJ
Eur J Cancer; 2010 Feb; 46(3):669-77. PubMed ID: 20022239
[TBL] [Abstract][Full Text] [Related]
16. Primary care physicians' use of an informed decision-making process for prostate cancer screening.
Volk RJ; Linder SK; Kallen MA; Galliher JM; Spano MS; Mullen PD; Spann SJ
Ann Fam Med; 2013; 11(1):67-74. PubMed ID: 23319508
[TBL] [Abstract][Full Text] [Related]
17. Informed decision making and prostate specific antigen (PSA) testing for prostate cancer: a randomised controlled trial exploring the impact of a brief patient decision aid on men's knowledge, attitudes and intention to be tested.
Watson E; Hewitson P; Brett J; Bukach C; Evans R; Edwards A; Elwyn G; Cargill A; Austoker J
Patient Educ Couns; 2006 Nov; 63(3):367-79. PubMed ID: 16875796
[TBL] [Abstract][Full Text] [Related]
18. Compliance with biopsy recommendations of a prostate cancer risk calculator.
van Vugt HA; Roobol MJ; Busstra M; Kil P; Oomens EH; de Jong IJ; Bangma CH; Steyerberg EW; Korfage I
BJU Int; 2012 May; 109(10):1480-8. PubMed ID: 21933335
[TBL] [Abstract][Full Text] [Related]
19. Prostate-specific antigen testing in Ontario: reasons for testing patients without diagnosed prostate cancer.
Bunting PS; Goel V; Williams JI; Iscoe NA
CMAJ; 1999 Jan; 160(1):70-5. PubMed ID: 9934349
[TBL] [Abstract][Full Text] [Related]
20. Screening for prostate cancer in asymptomatic men: clinical, legal, and ethical implications.
Gerard MJ; Frank-Stromborg M
Oncol Nurs Forum; 1998 Oct; 25(9):1561-9. PubMed ID: 9802052
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
